- Investing.com
Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Metrics to compare | NAN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNANPeersSector | |
---|---|---|---|---|
P/E Ratio | 81.0x | −2.7x | −0.5x | |
PEG Ratio | 18.92 | −0.04 | 0.00 | |
Price/Book | 7.1x | 2.5x | 2.6x | |
Price / LTM Sales | 7.3x | 2.1x | 3.1x | |
Upside (Analyst Target) | 2.9% | 245.8% | 48.3% | |
Fair Value Upside | Unlock | 23.5% | 7.6% | Unlock |